Longevity GlycanAge closes $8.7m to take glycan biomarkers into hospitalsBy adminDecember 20, 20250 Funding accelerates clinical rollout of glycan biomarkers for aging and inflammation, pushing them into mainstream preventive care. GlycanAge, a London-based…
Gut Health “Fantastic” deprescribing programme closes due to lack of fundingBy adminOctober 7, 20250 The National Polypharmacy Programme, a successful patient safety programme set up by doctors and pharmacists and run by the NHS’s…
